Integrin α2β1/α1β1 expression is reportedly regulated by VEGF, and an inhibitory antibody against α2β1/α1β1 has been shown to inhibit angiogenesis and tumour growth in VEGF-overexpressing tumour cells12, 18. This evidence concerns the gene VEGFA and neoplasm.